Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Under Trump, FDA seeks to abandon expert reviews of new drugs
FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications.
Arthur Allen, KFF Health News
Sep 12, 2025 9:50am
Marketing policy experts unfazed by threats to DTC advertising
Sep 12, 2025 4:20pm
Sponsored
Expert outlines emerging definitions, future research in CIDP care
Sep 8, 2025 8:00am
Trump officials to link COVID shots, child deaths: WaPo
Sep 12, 2025 2:47pm
Drug ads inspire action in patients with chronic disease: survey
Sep 12, 2025 1:17pm
What pharma and healthcare can learn from Doctor Mike
Sep 12, 2025 1:00pm
More News
Gilead claims victory in whistleblower kickback lawsuit
Sep 12, 2025 11:59am
Novartis falls in another IRA price negotiation loss for pharma
Sep 12, 2025 10:41am
Inside the commercial growing pains of hemophilia gene therapies
Sep 12, 2025 10:00am
Nominations open for Fiercest Women in Life Sciences 2025
Sep 12, 2025 7:00am